SG Americas Securities
IONS icon

SG Americas Securities’s Ionis Pharmaceuticals IONS Stock Holding History

SG Americas Securities’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-200,000
Closed -$20K – 2793
2014
Q4 		$20K Hold
200,000
– – ﹤0.01% 3063
2014
Q3 		$600K Buy
+200,000
New +$7.09M ﹤0.01% 1380

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SG Americas Securities's IONS Position: Q1 2026 in Review

SG Americas Securities increased its Ionis Pharmaceuticals (IONS) stake by 89% in Q1 2026, buying an estimated $2.36M and bringing the position to 63,295 shares worth $4.75M. The position accounts for 0.01% of the portfolio, ranked #1055.

SG Americas Securities first reported a position in IONS in Q2 2013 and has held it in 44 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • SG Americas Securities held 63,295 shares of Ionis Pharmaceuticals worth $4.75M as of Q1 2026.
  • SG Americas Securities bought 29,886 Ionis Pharmaceuticals shares in Q1 2026, an estimated $2.36M.
  • Ionis Pharmaceuticals made up 0.01% of SG Americas Securities's portfolio in Q1 2026, its #1055 holding.
  • SG Americas Securities first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 44 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.